Seminoma screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 5: Line 5:
==Overview==
==Overview==


There is insufficient evidence to recommend routine screening for [disease/malignancy].
According to the '''KIT'' Mutations Are Common in Testicular Seminomas' study, [[Screening (medicine)|screening]] for seminoma by using the highly sensitive combination of denaturing [[High performance liquid chromatography|high performance liquid chromatography (HPLC)]] and direct [[sequencing]].  
 
OR
 
According to the [guideline name], screening for [disease name] is not recommended.
 
OR
 
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
==Screening==
==Screening==
There is insufficient evidence to recommend routine screening for [disease/malignancy].
According to the '''KIT'' [[Mutation|Mutations]] Are Common in [[Testicular]] Seminomas' study, [[Screening (medicine)|screening]] for seminoma by using the highly sensitive combination of denaturing [[High performance liquid chromatography|high performance liquid chromatography (HPLC)]] and direct [[sequencing]] observed:<ref name="pmid14695343">{{cite journal |vauthors=Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC |title=KIT mutations are common in testicular seminomas |journal=Am. J. Pathol. |volume=164 |issue=1 |pages=305–13 |date=January 2004 |pmid=14695343 |pmc=1602213 |doi=10.1016/S0002-9440(10)63120-3 |url=}}</ref>
 
*[[Mutation|Mutations]] of KIT [[exon]] 17
OR
*[[Mutation|Mutations]] of D816H
 
*[[Mutation|Mutations]] of Y823D
According to the [guideline name], screening for [disease name] is not recommended.
 
OR
 
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
*[Condition 1]
*[Condition 2]
*[Condition 3]





Latest revision as of 16:57, 9 May 2019

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma screening

CDC on Seminoma screening

Seminoma screening in the news

Blogs on Seminoma screening

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

According to the 'KIT Mutations Are Common in Testicular Seminomas' study, screening for seminoma by using the highly sensitive combination of denaturing high performance liquid chromatography (HPLC) and direct sequencing.

Screening

According to the 'KIT Mutations Are Common in Testicular Seminomas' study, screening for seminoma by using the highly sensitive combination of denaturing high performance liquid chromatography (HPLC) and direct sequencing observed:[1]


References

  1. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC (January 2004). "KIT mutations are common in testicular seminomas". Am. J. Pathol. 164 (1): 305–13. doi:10.1016/S0002-9440(10)63120-3. PMC 1602213. PMID 14695343.

[[Category:Oncology]

Template:WH Template:WS